A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 119
[Display Entries]
100 entries :
      (Publication year, Descending)
100 entries :
      (Publication year, Ascending)
all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : AH
Long Form : atypical hyperplasia
No. Year Title Co-occurring Abbreviation
2020 Baseline Serum HE4 But Not Tissue HE4 Expression Predicts Response to the Levonorgestrel-Releasing Intrauterine System in Atypical Hyperplasia and Early Stage Endometrial Cancer. CI, EEC, LNG-IUS
2020 Congruence Between 1994 WHO Classification of Endometrial Hyperplasia and Endometrial Intraepithelial Neoplasia System. EIN, NAH, WHO
2020 Performance Characteristics of Endometrial Sampling in Diagnosis of Endometrial Carcinoma. EC
2019 Flat epithelial atypia on core needle biopsy does not always mandate excisional biopsy. CNB, DCIS, FEA, IDC, LCIS
2019 Gene Promoter Methylation in Endometrial Carcinogenesis. EC
2019 Histopathology and Clinical Outcomes of 151 Women with Postmenopausal Bleeding Treated with Resectoscopic Surgery. EC, HER, NAH, PMB
2019 Identification of endometrial cancers and atypical hyperplasia: Development and validation of a simplified system for ultrasound scoring of endometrial pattern. EC, ET, GIS, PMB, TVS
2019 Prevalence and predictors of atypical histology in endometrial polyps removed by hysteroscopy: A secondary analysis from the SICMIG hysteroscopy trial. EC, EPs
2019 Prolonged conservative treatment in patients with recurrent endometrial cancer after primary fertility-sparing therapy: 15-year experience. CR, EC, EIN
10  2019 The impact of obesity and bariatric surgery on circulating and tissue biomarkers of endometrial cancer risk. EC
11  2018 'No Pink Ribbons': How Women's Lived Experiences With Breast Atypia Inform Decisions Involving Risk-Reducing Medications. LCIS
12  2018 A System-Level Approach to Improve the Uptake of Antiestrogen Preventive Therapy among Women with Atypical Hyperplasia and Lobular Cancer In Situ. LCIS
13  2018 Diagnosis and Management of High-Risk Breast Lesions. LCIS
14  2018 Model for Predicting Breast Cancer Risk in Women With Atypical Hyperplasia. BC
15  2018 Performance Characteristics of Endometrial Sampling in Diagnosis of Endometrial Carcinoma. EC
16  2018 Serum microRNA as potential biomarker to detect breast atypical hyperplasia and early-stage breast cancer. BC, miRNA
17  2017 Mammographic breast density and risk of breast cancer in women with atypical hyperplasia: an observational cohort study from the Mayo Clinic Benign Breast Disease (BBD) cohort. BBD, BC, MBD, NP, PD, PDWA, PP, SIRs
18  2017 MRI surveillance for women with dense breasts and a previous breast cancer and/or high risk lesion. BC, CDR, FP, LCIS
19  2016 Breast cancer risk by extent and type of atypical hyperplasia: An update from the Nurses' Health Studies. ADH, ALH, CI, OR
20  2016 Extent of atypical hyperplasia stratifies breast cancer risk in 2 independent cohorts of women. ADH, ALH, BC
21  2016 Mucocele-like lesions of the breast: a clinical outcome and histologic analysis of 102 cases. MLLs
22  2015 Flat epithelial atypia and risk of breast cancer: A Mayo cohort study. FEA, PDWA, SIRs
23  2015 Impact of preventive therapy on the risk of breast cancer among women with benign breast disease. AIs, LCIS
24  2014 Accuracy of screening mammography in women with a history of lobular carcinoma in situ or atypical hyperplasia of the breast. ADH, ALH, BC, CDR, ICR, LCIS
25  2014 DNA methylation as a biomarker for the detection of hidden carcinoma in endometrial atypical hyperplasia. EC
26  2014 Estrogen receptor beta2 is inversely correlated with Ki-67 in hyperplastic and noninvasive neoplastic breast lesions. AM, DCIS, HUT, Ki-67 LI
27  2014 Impact of atypical hyperplasia at margins of breast-conserving surgery on the recurrence of breast cancer. BCS, DMFS, IBTR, OS
28  2014 Impact of obesity on the results of fertility-sparing management for atypical hyperplasia and grade 1 endometrial cancer. BMI, EC
29  2014 Insulin-like growth factor-I inhibition with pasireotide decreases cell proliferation and increases apoptosis in pre-malignant lesions of the breast: a phase 1 proof of principle trial. DCIS, ER, IGF-I, PR
30  2014 Intrahepatic interleukin-17+ T cells and FoxP3+ regulatory T cells cooperate to promote development and affect the prognosis of hepatocellular carcinoma. CHB, DFS, HCC, IL, OS
31  2014 The steroid receptor coactivator-3 is required for developing neuroendocrine tumor in the mouse prostate. NETCs
32  2013 A prospective study of fertility-sparing treatment with megestrol acetate following hysteroscopic curettage for well-differentiated endometrioid carcinoma and atypical hyperplasia in young women. EC, MA
33  2013 Gradually increased Golgi protein 73 expression in the progression of benign liver diseases to precancerous lesions and hepatocellular carcinoma correlates with prognosis of patients. CHB, HCC, LC, NC, PTL, sGP73, tGP73
34  2013 Three-dimensional nuclear telomere architecture changes during endometrial carcinoma development. EC, SH
35  2012 Atypical hyperplasia of the breast: the black hole of routine breast cancer screening. ---
36  2012 Atypical hyperplasia on core biopsy: is further surgery needed? CNB
37  2012 Identification of candidate biomarkers for early detection of human lung squamous cell cancer by quantitative proteomics. CIS, LSCC, NBE, SM
38  2012 Progestin treatment of atypical hyperplasia and well-differentiated adenocarcinoma of the endometrium to preserve fertility. EC
39  2012 [Fertility sparing management of endometrial adenocarcinoma and atypical hyperplasia: a literature review]. EC
40  2011 Correlation of ductal lavage cytology with ductoscopy-directed duct excision histology in women at high risk for developing breast cancer: a prospective, single-institution trial. DCIS
41  2011 Estrogen receptor expression in atypical hyperplasia: lack of association with breast cancer. ADH, ALH, ER
42  2011 p16(INK4a) expression and breast cancer risk in women with atypical hyperplasia. DCIS
43  2011 Preoperative risk assessment among women undergoing bilateral prophylactic mastectomy for cancer risk reduction. BPM, DCIS, LCIS
44  2011 The differences in imaging features of malignant and benign branch duct type of Intraductal Papillary Mucinous Tumor. IPMT
45  2011 The influence of family history and histological stratification on breast cancer risk in women with benign breast disease: a meta-analysis. ADH, ALH, BBD, NP
46  2010 Columnar cell lesions and subsequent breast cancer risk: a nested case-control study. BBD, CCL, CIs, ORs
47  2010 Expression of Efp, VEGF and bFGF in normal, hyperplastic and malignant endometrial tissue. bFGF, EC, Efp, NE, VEGF
48  2009 Aberrant DNA hypermethylation of hMLH-1 and CDKN2A/p16 genes in benign, premalignant and malignant endometrial lesions. EC, EP
49  2009 Endometrial hyperplasia and the risk of progression to carcinoma. CAH, EH, WHO
50  2009 Fertility-preserving treatment in young women with well-differentiated endometrial carcinoma and severe atypical hyperplasia of endometrium. EC
51  2009 Frequency and characteristics of endometrial carcinoma and atypical hyperplasia detected on routine infertility investigations in young women: a report of six cases. EC
52  2009 Potential therapeutic significance of increased expression of aryl hydrocarbon receptor in human gastric cancer. AhR, CAG, CSG, GC, IHC, IM, TCDD
53  2009 Reproducibility determination of WHO classification of endometrial hyperplasia/well differentiated adenocarcinoma and comparison with computerized morphometric data in curettage specimens in Iran. CH, EH, EIN, SH, VPS, WDA
54  2009 [Evaluation of angiogenesis in the tumorigenesis and progression of breast cancer]. MVD, VEGF
55  2009 [Inspection on angiogenesis in malignant transformation of breast tumor by ultrasound contrast and quantitative analysis]. AUC, MVI, PI, VEGF, WOT
56  2008 Breast cancer risk in women with radial scars in benign breast biopsies. BBD, PDWA, RS
57  2008 High frequency of RASSF1A and RARb2 gene promoter methylation in morphologically normal endometrium adjacent to endometrioid adenocarcinoma. EEC
58  2008 Histologic associations and long-term cancer risk in columnar cell lesions of the breast: a retrospective cohort and a nested case-control study. CCL, RR
59  2008 Risk of subsequent endometrial carcinoma associated with endometrial intraepithelial neoplasia classification of endometrial biopsies. DPEM, EH, EIN, RRs, WHO
60  2008 [Incidence of endometrial carcinoma after hysterectomy for atypical hyperplasia or FIGO stage IA carcinoma diagnosed on endometrial biopsy or endometrial resection]. ---
61  2007 Beneficial properties of melatonin in an experimental model of pancreatic cancer. LPO
62  2007 Comparison of ductal lavage and random periareolar fine needle aspiration as tissue acquisition methods in early breast cancer prevention trials. DL, RPFNA
63  2007 Magnitude and laterality of breast cancer risk according to histologic type of atypical hyperplasia: results from the Nurses' Health Study. ADH, ALH, OR
64  2007 Results of MRI screening for breast cancer in high-risk patients with LCIS and atypical hyperplasia. LCIS, MRI
65  2006 An analysis of breast cancer risk in women with single, multiple, and atypical papilloma. CI
66  2006 In utero exposure to diethylstilbestrol (DES) does not increase genomic instability in normal or neoplastic breast epithelium. AI, DES, IC, LOH, MI, NCI, RR
67  2006 The influence of family history on breast cancer risk in women with biopsy-confirmed benign breast disease: results from the Nurses' Health Study. BBD, FH, OR
68  2004 A prospective study of diet and benign breast disease. BBD, RR
69  2004 Acceptance of tamoxifen chemoprevention by physicians and women at risk. LCIS, NSABP
70  2004 Frequency of benign and preinvasive breast diseases. CIS, KSA, MIN, SNOMED
71  2004 [Association of TGFalpha and cyclin E expression in gastric carcinoma and precancerous lesions]. CSG, GCA, IM
72  2003 Does hormone replacement therapy increase the frequency of breast atypical hyperplasia in postmenopausal women? Results from the Bouches du Rhone district screening campaign. CI, HRT, OR
73  2003 Endometrial brush biopsy. An accurate outpatient method of detecting endometrial malignancy. AT, BE, CA, ND
74  2002 Evaluating post-treatment screening in women with breast cancer. CBE, CIS
75  2001 Atypical ductal hyperplasia in stereotactic breast biopsies: enhanced accuracy of diagnosis with the mammotome. ADH, ATC, DCIS, SMBs
76  2001 Atypical hyperplasia, proliferative fibrocystic change, and exogenous hormone use. EHU, NPFC, PFC
77  2001 Conservative therapy for adenocarcinoma and atypical endometrial hyperplasia of the endometrium in young women: central pathologic review and treatment outcome. EA, MPA
78  2001 [Bax gene expression in endometrial carcinoma]. EC, NPE, SCH
79  2001 [Therapy of atypical hyperplasia and adenocarcinoma of the endometrium with the combination of progestins and anticoagulants]. CAC
80  2000 Carcinoma in situ of the female breast. 10 year follow-up results of a prospective nationwide study. DCIS, IC, LCIS
81  2000 Lack of involvement of metallothionein expression in pancreatic carcinogenesis by N-nitrosobis (2-oxopropyl) amine in Syrian hamsters. BW, MT, s.c
82  2000 Neoplastic and pre-neoplastic changes in gastrointestinal endometriosis: a study of 17 cases. ACIS, ANED, EA, EBA, ESS, MAS
83  2000 Treating breast precancer. DCIS, IEN
84  2000 [Methylation and expression of the p16 gene in endometrial carcinoma]. EC, NE, SCH
85  1999 Carcinogenicity of heterocyclic amines for the pancreatic duct epithelium in hamsters. CD, CIS, HCAs, PhIP
86  1999 Estrogen replacement therapy in women with a history of proliferative breast disease. CFA, ERT, PDWA
87  1999 Expression pattern of a newly recognized protein, LECT2, in hepatocellular carcinoma and its premalignant lesion. LECT2, LGM-HCC
88  1998 Atypical hyperplasia in the era of stereotactic core needle biopsy. DCIS, SCNB
89  1998 Image-guided or needle-localized open biopsy of mammographic malignant-appearing microcalcifications? CIS, IGBB, NLOB
90  1998 Reproducibility of the diagnosis of endometrial hyperplasia, atypical hyperplasia, and well-differentiated carcinoma. PEM
91  1998 The presence of proliferative breast disease with atypia does not significantly influence outcome in early-stage invasive breast cancer treated with conservative surgery and radiation. LCIS
92  1997 Microsatellite alterations indicating monoclonality in atypical hyperplasias associated with breast cancer. PCR
93  1996 Detection of monoclonal microsatellite alterations in atypical breast hyperplasia. ---
94  1996 Papillary apocrine change of the breast: associations with atypical hyperplasia and risk of breast cancer. PAC
95  1996 Subsequent breast carcinoma risk after biopsy with atypia in a breast papilloma. ---
96  1996 Thickened endometrial stripe and/or endometrial fluid as a marker of pathology: fact or fancy? CA, EF, ES
97  1994 Application of the image analysis system and Imago program to biological samples. nucl, WDA
98  1994 Cell proliferation in hyperplastic and in situ carcinoma lesions of the breast estimated by in vivo labeling with bromodeoxyuridine. BrdU, CIS, ICa, NAH
99  1994 Consistency of histopathological reporting of breast lesions detected by screening: findings of the U.K. National External Quality Assessment (EQA) Scheme. U. K. National Coordinating Group for Breast Screening Pathology. DCIS, EQA
100  1993 Breast cancer risk associated with proliferative breast disease and atypical hyperplasia. BCDDP, CI, FH, PD